Cargando…

Breast PET/MRI Hybrid Imaging and Targeted Tracers

The recent introduction of hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) as a promising imaging modality for breast cancer assessment has prompted fervent research activity on its clinical applications. The current knowledge regarding the possible clinical applications of...

Descripción completa

Detalles Bibliográficos
Autores principales: Romeo, Valeria, Helbich, Thomas H., Pinker, Katja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074861/
https://www.ncbi.nlm.nih.gov/pubmed/36165348
http://dx.doi.org/10.1002/jmri.28431
_version_ 1785019820084822016
author Romeo, Valeria
Helbich, Thomas H.
Pinker, Katja
author_facet Romeo, Valeria
Helbich, Thomas H.
Pinker, Katja
author_sort Romeo, Valeria
collection PubMed
description The recent introduction of hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) as a promising imaging modality for breast cancer assessment has prompted fervent research activity on its clinical applications. The current knowledge regarding the possible clinical applications of hybrid PET/MRI is constantly evolving, thanks to the development and clinical availability of hybrid scanners, the development of new PET tracers and the rise of artificial intelligence (AI) techniques. In this state‐of‐the‐art review on the use of hybrid breast PET/MRI, the most promising advanced MRI techniques (diffusion‐weighted imaging, dynamic contrast‐enhanced MRI, magnetic resonance spectroscopy, and chemical exchange saturation transfer) are discussed. Current and experimental PET tracers ((18)F‐FDG, (18)F‐NaF, choline, (18)F‐FES, (18)F‐FES, (89)Zr‐trastuzumab, choline derivatives, (18)F‐FLT, and (68)Ga‐FAPI‐46) are described in order to provide an overview on their molecular mechanisms of action and corresponding clinical applications. New perspectives represented by the use of radiomics and AI techniques are discussed. Furthermore, the current strengths and limitations of hybrid PET/MRI in the real world are highlighted. EVIDENCE LEVEL: 2 TECHNICAL EFFICACY: Stage 2
format Online
Article
Text
id pubmed-10074861
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-100748612023-04-12 Breast PET/MRI Hybrid Imaging and Targeted Tracers Romeo, Valeria Helbich, Thomas H. Pinker, Katja J Magn Reson Imaging Reviews The recent introduction of hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) as a promising imaging modality for breast cancer assessment has prompted fervent research activity on its clinical applications. The current knowledge regarding the possible clinical applications of hybrid PET/MRI is constantly evolving, thanks to the development and clinical availability of hybrid scanners, the development of new PET tracers and the rise of artificial intelligence (AI) techniques. In this state‐of‐the‐art review on the use of hybrid breast PET/MRI, the most promising advanced MRI techniques (diffusion‐weighted imaging, dynamic contrast‐enhanced MRI, magnetic resonance spectroscopy, and chemical exchange saturation transfer) are discussed. Current and experimental PET tracers ((18)F‐FDG, (18)F‐NaF, choline, (18)F‐FES, (18)F‐FES, (89)Zr‐trastuzumab, choline derivatives, (18)F‐FLT, and (68)Ga‐FAPI‐46) are described in order to provide an overview on their molecular mechanisms of action and corresponding clinical applications. New perspectives represented by the use of radiomics and AI techniques are discussed. Furthermore, the current strengths and limitations of hybrid PET/MRI in the real world are highlighted. EVIDENCE LEVEL: 2 TECHNICAL EFFICACY: Stage 2 John Wiley & Sons, Inc. 2022-09-27 2023-02 /pmc/articles/PMC10074861/ /pubmed/36165348 http://dx.doi.org/10.1002/jmri.28431 Text en © 2022 The Authors. Journal of Magnetic Resonance Imaging published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Romeo, Valeria
Helbich, Thomas H.
Pinker, Katja
Breast PET/MRI Hybrid Imaging and Targeted Tracers
title Breast PET/MRI Hybrid Imaging and Targeted Tracers
title_full Breast PET/MRI Hybrid Imaging and Targeted Tracers
title_fullStr Breast PET/MRI Hybrid Imaging and Targeted Tracers
title_full_unstemmed Breast PET/MRI Hybrid Imaging and Targeted Tracers
title_short Breast PET/MRI Hybrid Imaging and Targeted Tracers
title_sort breast pet/mri hybrid imaging and targeted tracers
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074861/
https://www.ncbi.nlm.nih.gov/pubmed/36165348
http://dx.doi.org/10.1002/jmri.28431
work_keys_str_mv AT romeovaleria breastpetmrihybridimagingandtargetedtracers
AT helbichthomash breastpetmrihybridimagingandtargetedtracers
AT pinkerkatja breastpetmrihybridimagingandtargetedtracers